FDA Offers $4,000 To Cover Cost Of Third-Party Review Expenses
FDA would provide the first $4,000 to help companies defray the cost of third-party 510(k) review for eligible devices, the agency explains in its FY 2001 budget justification document.
FDA would provide the first $4,000 to help companies defray the cost of third-party 510(k) review for eligible devices, the agency explains in its FY 2001 budget justification document.